A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib
- Status
- TERMINATED
- Phase
- PHASE1
Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015
- Status
- COMPLETED
- Phase
- PHASE1
A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation
- Status
- UNKNOWN
- Phase
- PHASE1
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of LY3405105 in Participants With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of ICP-192 in Solid Tumors Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of LY3415244 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
- Status
- RECRUITING
- Phase
- N/A